Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: Treatment for Legg-Calvé-Perthes disease focuses on maintaining hip range of motion and protecting the femoral head while it undergoes revascularization and healing. Management strategies range from activity modification and physical therapy to surgical intervention, and the best approach is determined by the patient's age at onset, the extent of hip involvement, and the stage of disease progression. What are the primary treatment goals for Legg-Calvé-Perthes disease? The core objective in managing Legg-Calvé-Perthes disease is to ensure the femoral head remains contained within the acetabulum (the hip socket) while the bone regenerates.
2 people with Legg-Calvé-Perthes disease have shared their first-person experience on this question at DiseaseMaps.
TL;DR: Treatment for Legg-Calvé-Perthes disease focuses on maintaining hip range of motion and protecting the femoral head while it undergoes revascularization and healing. Management strategies range from activity modification and physical therapy to surgical intervention, and the best approach is determined by the patient's age at onset, the extent of hip involvement, and the stage of disease progression.
The core objective in managing Legg-Calvé-Perthes disease is to ensure the femoral head remains contained within the acetabulum (the hip socket) while the bone regenerates. Because the blood supply to the femoral head is temporarily disrupted, the bone becomes soft and prone to deformity. By keeping the hip well-seated, clinicians aim to minimize long-term damage, prevent stiffness, and reduce the risk of early-onset osteoarthritis. Treatment for Legg-Calvé-Perthes disease is highly individualized; a child diagnosed at age 5 generally has a significantly better prognosis than a child diagnosed after age 8.
Treatment for Legg-Calvé-Perthes disease is often categorized by the severity of the condition and the "containment" of the hip joint. Clinical management usually includes:
Because Legg-Calvé-Perthes disease involves both orthopedic structural integrity and long-term musculoskeletal function, a multidisciplinary approach is essential. Your care team should ideally include:
There are no FDA-approved medications that "cure" or reverse the underlying pathology of Legg-Calvé-Perthes disease. Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen are commonly prescribed to manage pain and reduce synovial inflammation. Current research is investigating the use of bisphosphonates to maintain bone density during the revascularization phase, but these are not yet considered standard practice. Clinical trials continue to explore regenerative medicine techniques, but these remain experimental.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; all treatment decisions must be made in consultation with your child’s specialized medical team.